An analysis of orphan medicine expenditure in Europe: is it sustainable?
Abstract Background Orphan medicinal product (OMP) prices are considered by some to be a challenge to the sustainability of healthcare expenditure. These concerns are compounded by the increasing number of OMPs receiving marketing authorisation (MA) annually. The aim of this study was to explore the...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2019-12-01
|
| Rangatū: | Orphanet Journal of Rare Diseases |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s13023-019-1246-7 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|